Cargando…

Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study

Objectives: To update the epidemiology and susceptibility of hospital-acquired (HA) and community-acquired (CA), as well as intensive care unit (ICU) vs non-ICU-derived intra-abdominal infection (IAI) and urinary tract infection (UTI) pathogens in Chinese hospitals. Methods: A total of 2,546 Gram-ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hui, Johnson, Aaron, Zhang, Ge, Yang, Yang, Zhang, Jingjia, Li, Dongxue, Duan, Simeng, Yang, Qiwen, Xu, Yingchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503304/
https://www.ncbi.nlm.nih.gov/pubmed/31118698
http://dx.doi.org/10.2147/IDR.S203572
_version_ 1783416382392631296
author Zhang, Hui
Johnson, Aaron
Zhang, Ge
Yang, Yang
Zhang, Jingjia
Li, Dongxue
Duan, Simeng
Yang, Qiwen
Xu, Yingchun
author_facet Zhang, Hui
Johnson, Aaron
Zhang, Ge
Yang, Yang
Zhang, Jingjia
Li, Dongxue
Duan, Simeng
Yang, Qiwen
Xu, Yingchun
author_sort Zhang, Hui
collection PubMed
description Objectives: To update the epidemiology and susceptibility of hospital-acquired (HA) and community-acquired (CA), as well as intensive care unit (ICU) vs non-ICU-derived intra-abdominal infection (IAI) and urinary tract infection (UTI) pathogens in Chinese hospitals. Methods: A total of 2,546 Gram-negative isolates from IAIs and 1,947 isolates from UTIs collected in 16 hospitals and 7 regions of China from 2016 to 2017 were analyzed. Results: E. coli and K. pneumoniae were the most common pathogens identified in HA (40.7%, 21.9%) and CA (49.2%, 21.3%) IAIs and in HA (59.0%, 17.3%) and CA (64.3%, 12.7%) UTIs, respectively. The overall rates of extended-spectrum β-lactamase (ESBL)-positive strains were 48.2% for E. coli and 26.4% for K. pneumoniae. The rates of ESBL-positive E. coli and K. pneumoniae strains were significantly higher in HA than in CA IAIs (51.7% vs 42.4%, P=0.016 and 22.0% vs 20.6%, P<0.001). IAI E. coli ESBL-producing isolates were most susceptible to IPM (97.2%) and AMK (93.9%), and UTI-associated E. coli ESBL-producers were 94.74% susceptible to amikacin (AMK), 97.02% to imipenem (IPM), and 91.4% to ertapenem (ETP). IAI K. pneumoniae ESBL-producing isolates were most susceptible to AMK (84.43%) and IPM (82.79%), and UTI-associated K. pneumoniae ESBL-producers were 88.39% susceptible to AMK, 87.5% to IPM, and 82.14% to ETP. Overall, percentages of susceptible strains to ETP, IPM, AMK, and Piperacillin-Tazobactam (TZP) were in the range of 82.0% to 96.4%, to 5 cephalosporins in the range of 31.4%-69.6% and to 2 fluoroquinolones in the range of 37.8%-45.5% for E. coli and 65.5%-90.7%, 37.7%-75.3%, and 43.9%-73.2% for K. pneumoniae, respectively. Conclusion: E. coli and K. pneumoniae continued to be the main pathogens in Chinese UTIs and IAIs with high ESBL-positive rates between 2016 and 2017. Carbapenem- or amikacin-based therapies were the most effective to combat IAI and UTI pathogens.
format Online
Article
Text
id pubmed-6503304
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-65033042019-05-22 Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study Zhang, Hui Johnson, Aaron Zhang, Ge Yang, Yang Zhang, Jingjia Li, Dongxue Duan, Simeng Yang, Qiwen Xu, Yingchun Infect Drug Resist Original Research Objectives: To update the epidemiology and susceptibility of hospital-acquired (HA) and community-acquired (CA), as well as intensive care unit (ICU) vs non-ICU-derived intra-abdominal infection (IAI) and urinary tract infection (UTI) pathogens in Chinese hospitals. Methods: A total of 2,546 Gram-negative isolates from IAIs and 1,947 isolates from UTIs collected in 16 hospitals and 7 regions of China from 2016 to 2017 were analyzed. Results: E. coli and K. pneumoniae were the most common pathogens identified in HA (40.7%, 21.9%) and CA (49.2%, 21.3%) IAIs and in HA (59.0%, 17.3%) and CA (64.3%, 12.7%) UTIs, respectively. The overall rates of extended-spectrum β-lactamase (ESBL)-positive strains were 48.2% for E. coli and 26.4% for K. pneumoniae. The rates of ESBL-positive E. coli and K. pneumoniae strains were significantly higher in HA than in CA IAIs (51.7% vs 42.4%, P=0.016 and 22.0% vs 20.6%, P<0.001). IAI E. coli ESBL-producing isolates were most susceptible to IPM (97.2%) and AMK (93.9%), and UTI-associated E. coli ESBL-producers were 94.74% susceptible to amikacin (AMK), 97.02% to imipenem (IPM), and 91.4% to ertapenem (ETP). IAI K. pneumoniae ESBL-producing isolates were most susceptible to AMK (84.43%) and IPM (82.79%), and UTI-associated K. pneumoniae ESBL-producers were 88.39% susceptible to AMK, 87.5% to IPM, and 82.14% to ETP. Overall, percentages of susceptible strains to ETP, IPM, AMK, and Piperacillin-Tazobactam (TZP) were in the range of 82.0% to 96.4%, to 5 cephalosporins in the range of 31.4%-69.6% and to 2 fluoroquinolones in the range of 37.8%-45.5% for E. coli and 65.5%-90.7%, 37.7%-75.3%, and 43.9%-73.2% for K. pneumoniae, respectively. Conclusion: E. coli and K. pneumoniae continued to be the main pathogens in Chinese UTIs and IAIs with high ESBL-positive rates between 2016 and 2017. Carbapenem- or amikacin-based therapies were the most effective to combat IAI and UTI pathogens. Dove 2019-04-24 /pmc/articles/PMC6503304/ /pubmed/31118698 http://dx.doi.org/10.2147/IDR.S203572 Text en © 2019 Zhang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Hui
Johnson, Aaron
Zhang, Ge
Yang, Yang
Zhang, Jingjia
Li, Dongxue
Duan, Simeng
Yang, Qiwen
Xu, Yingchun
Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study
title Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study
title_full Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study
title_fullStr Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study
title_full_unstemmed Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study
title_short Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study
title_sort susceptibilities of gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the chinese smart study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503304/
https://www.ncbi.nlm.nih.gov/pubmed/31118698
http://dx.doi.org/10.2147/IDR.S203572
work_keys_str_mv AT zhanghui susceptibilitiesofgramnegativebacillifromhospitalandcommunityacquiredintraabdominalandurinarytractinfectionsa20162017updateofthechinesesmartstudy
AT johnsonaaron susceptibilitiesofgramnegativebacillifromhospitalandcommunityacquiredintraabdominalandurinarytractinfectionsa20162017updateofthechinesesmartstudy
AT zhangge susceptibilitiesofgramnegativebacillifromhospitalandcommunityacquiredintraabdominalandurinarytractinfectionsa20162017updateofthechinesesmartstudy
AT yangyang susceptibilitiesofgramnegativebacillifromhospitalandcommunityacquiredintraabdominalandurinarytractinfectionsa20162017updateofthechinesesmartstudy
AT zhangjingjia susceptibilitiesofgramnegativebacillifromhospitalandcommunityacquiredintraabdominalandurinarytractinfectionsa20162017updateofthechinesesmartstudy
AT lidongxue susceptibilitiesofgramnegativebacillifromhospitalandcommunityacquiredintraabdominalandurinarytractinfectionsa20162017updateofthechinesesmartstudy
AT duansimeng susceptibilitiesofgramnegativebacillifromhospitalandcommunityacquiredintraabdominalandurinarytractinfectionsa20162017updateofthechinesesmartstudy
AT yangqiwen susceptibilitiesofgramnegativebacillifromhospitalandcommunityacquiredintraabdominalandurinarytractinfectionsa20162017updateofthechinesesmartstudy
AT xuyingchun susceptibilitiesofgramnegativebacillifromhospitalandcommunityacquiredintraabdominalandurinarytractinfectionsa20162017updateofthechinesesmartstudy